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Recent reports that myelin basic protein (MBP) can be ADP-ribosylated and contains specific sites that bind GTP and 
Gu, ganglioside, have suggested an analogy to the properties of cholera toxin. Comparisons of pairs of sequences between 
these two proteins yielded two regions of homology between MBP and the cholera toxin B (chol B) subunit, and one 
region of homology with the cholera toxin A (chol A) subunit. The matching sites within chol B consisted of a 17 amino 
acid residue sequence (residues 3046 in chol B and residues 102-I 18 in human-MBP, hMBP, p < 0.0007) and an 11 resi- 
due span (residues 3141 in chol B and sequence 29-39 in hMBP, p<O.O004). The homologous ite within chol A cor- 
responded to an 11 residue span (residues 130-140 in chol A and 67-77 in hMBP sequence, p < 0.00007). Since portions 
of the cholera toxin sequence are virtually identical to sections of the sequence in E. coli toxin, the homology is also 
valid for the same sequences in this toxin. The highly antigemc behavior of MBP that is related to the induction of experi- 
mental allergic encephalomyelitis may be paralleled by comparable neural pathology from the homologous regions of 
cholera toxin. 
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Central nervous system myelin basic protein 
(MBP) is a peripheral membrane protein that 
possesses ome unique properties not common to 
other peripheral membrane proteins. The isoelec- 
tric point is greater than 10.6 [l], it binds GM~ 
ganglioside [2], GTP [3], and it can be ADP- 
ribosylated [4]. The protein and some of its pep- 
tides are highly antigenic, and are capable of in- 
ducing experimental allergic encephalomyelitis, 
EAE, in a number of laboratory animals. This pro- 
tein has been the focus of innumerable investiga- 
tions because of its possible role in the etiology of 
multiple sclerosis and other demyelinating con- 
ditions. 
In the mid 196Os, Tomasi and Kornguth [5] sug- 
gested that MBP and histone were related proteins. 
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However, it was subsequently shown that the pro- 
tein these investigators had isolated was, in fact, 
MBP and not histone [6]. Jahnke et al. [7] search- 
ed the protein sequence database, version 3.0, for 
sequence homologies between MBP and viral pro- 
teins. This resulted in the identification of 23 pep- 
tide sequences from different viruses which could 
be matched with appropriate sequences in MBP. 
Quite recently it was suggested that the 21.5 kDa 
human MBP and the protein from visna virus con- 
tained a region of sequence homology [8]. 
Cholera toxin is a complex consisting of a single 
A (chol A) subunit and five B (chol B) subunits. 
The B subunits bind to cell membranes by an in- 
teraction with the GM~ ganglioside (& = 1 x 
10m9 M) whereas the A subunit facilitates the 
ADP-ribosylation of signal transducing G-type 
proteins. The similarity between MBP and cholera 
toxin is strengthened by the reports that MBP ex- 
hibits binding properties that are similar to those 
of cholera toxin. 
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The binding of GM~ ganglioside by chol B is 
paralleled by the MBP binding of GM~. The in- 
vestigations by Yu and his collaborators [2] show- 
ed that the interaction of GMMI ganglioside with 
MBP occurred in the region of the molecule com- 
prising amino acid residues in proximity to tryp- 
tophan 116. The interaction of the single 
methylated arginine 107 residue with the GM~ 
molecule was also confirmed. It has been reported 
[9] that in chol B the chemical modification of Arg 
35 blocked the binding of GM~. In addition, the 
binding of GM~ also encompassed a region of 
hydrophobicity in the toxin suggesting an accom- 
modation of the hydrophobic chain of the 
glycolipid [9]. 
The analogy to chol A behavior is strengthened 
by recent reports from the Moscarello laboratory 
[3], that GTP is bound to the N-terminal region of 
human MBP and that MBP can also be ADP- 
ribosylated [4]. 
These reports on MBP behavior led us to com- 
pare sequences of MBP for possible structural 
similarity with that of chol A and B. The primary 
structure for chol A has been reported [lo, 1 l] and 
the amino acid sequence for chol B is also known 
[ 13,141. The amino acid sequence of the E. coli LT 
enterotoxin is very similar to that of chol A and is 
reported to show a homology of approximately 
81% [12]. Thus this toxin will have the same 
homology to MBP as does chol A. 
The amino acid sequence of human MBP was 
compared with that of chol A and B subunits using 
the Staden program DIAGON [15,16] run on a 
VAX computer. Initial matching was based on 
11-residue spans using a score threshold at the 
0.1% level of expectation 0, < O.OOl), as calculated 
by the McLachlan [ 171 double matching probabili- 
ty. After a sequence match had been recognized, 
the residue span and the score threshold were in- 
creased to find the lowest p value compatible with 
that particular match. These sequence matching 
determinations revealed that a portion of the chol 
B unit, consisting of amino acid residues 30-46, 
was homologous to a region of the MBP molecule 
comprising amino acid residues 102-l 18. The p 
value for the validity of this correlation was lower 
than 0.0007. This 17 amino acid sequence was the 
largest homology match that could be validated. A 
smaller 11 amino acid segment encompassing 
hMBP residues 29-39 was also matched to the 
same region (31-41 in the chol B sequence) with a 
p value of 0.0004. The numbering of the MBP se- 
quence is the one used for bovine MBP as given by 
Martenson et al. [6]. 
SQGKGRGLSLSRFSWGA humanMBP 
102 118 p < 0.0007 
S LAGKREMAI I TFKNGA choleratoxinB 
30 46 
LPRHRDTGI LD human MBP 
29 39 p<0.0004 
The homology found between chol A and MBP 
involved the chol A residues 130-140 and 53-64, 
that matched residues 67-77 and 8-20 in the MBP 
sequence, respectively. 
VHFGVLDEQLH 
130 140 
AHYGSLPQKSH 
67 77 
cholera toxin A 
human MBP 
p < o.oooo7 
VRHDDGYVSTSI cholera toxin A 
53 64 
QRHGSKYLATAS human MBP 
8 20 p < 0.0001 
Sequence alignment and homology reveal 
several noteworthy features. The primary feature 
is the alignment of arginine 35 in cholera B with 
arginine 107 in MBP. Each of these respective 
residues has been reported to be a participant in 
the binding of GMMI ganglioside [2,9]. The second 
feature is the closeness of the tryptophan residue to 
this arginine in MBP. The NMR study [2] also im- 
plicated this residue in the binding of the GM~ 
ganglioside. Although the attachment of azido 
GTP is reported to occur in MBP at glutamine 
residue 3 [3], the peptide sequence homology with 
chol A occurs from residues 8 to 20. This small se- 
quence displacement does not detract from the 
homology that has been identified, since elements 
of secondary and tertiary structure could influence 
the placement of the GTP on equivalent 
glutamines in the region. All four MBP segments 
that were found to be homologous to cholera toxin 
correlate with conserved sequence regions [26] of 
the MBP molecule. This would be expected if they 
were essential for myelin structure and function. 
These features of parahel properties, that can be 
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related to homologies in peptide sequences, may 
also be reflected in the antigenic properties of the 
cholera toxin homologous peptides. In human 
MBP the sequence from residue 43 to 88 is a domi- 
nant antigenic form present in cerebrospinal fluid 
after myelin injury 1181 and contains the major 
encephalitogenic determinant reported to be 
responsible for EAE in Lewis rat [19], rabbit [20] 
and monkey [21]. This sequence contains the 
epitope residues 64-75 [22], which are part of the 
MBP sequence 67-77 that in turn is homologous 
to the chol A segment of amino acids 130 to 140. 
Incidents of neural pathology that were correlated 
with the subcutaneous administration of cholera 
vaccines are reported in the literature [23]. 
Neurological complications resulting from vac- 
cines are not uncommon [24]. These vaccines may 
have contained small amounts of the toxin [24] 
and, in the most severe responses elicited a strong 
antibody response accompanied by encephalo- 
myelitis [25]. It has been claimed that only six 
amino acids appear to be necessary to define an an- 
tigenic determinant [8] so that the delineated 
homology may be sufficient to elicit the neuro- 
logical complication. However, the X-ray crystal 
structure of the lysozyme antibody complex from 
the Poljak group [27] reveals that there is an ap- 
proximately 700 A2 interface of accessible surface 
area of the antibody combing site. Thus, there are 
many more contacts than just the antigenic deter- 
minants and the question of what defines an an- 
tigenic determinant is much more complicated. 
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